Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage?
Open Access
- 11 August 2009
- journal article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 24 (12) , 3632-3640
Abstract
Background. In clinical renal transplantation, an increase in proteinuria after conversion from calcineurin inhibitors to rapamycin has been reported. In contrast, there are studies showing a nephro-protective effect of rapamycin in proteinuric diseases characterized by progressive interstitial inflammatory fibrosis.Keywords
This publication has 42 references indexed in Scilit:
- The mTOR Inhibitor Everolimus Induces Proteinuria and Renal Deterioration in the Remnant Kidney Model in the RatTransplantation, 2007
- Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AMLBlood, 2006
- Rapamycin worsens renal function and intratubular cast formation in protein overload nephropathyKidney International, 2005
- Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimusNephrology Dialysis Transplantation, 2005
- Direct electrotransfer of hHGF gene into kidney ameliorates ischemic acute renal failureGene Therapy, 2005
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005
- Reduction of Postischemic Immune Inflammatory Response: An Effective Strategy for Attenuating Chronic Allograft NephropathyTransplantation, 2005
- Increased oxidative stress and apoptosis in acute puromycin aminonucleoside nephrosisInternational Journal of Experimental Pathology, 2004
- Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidneyKidney International, 2003
- Glomerular permeability barrier in the rat. Functional assessment by in vitro methods.Journal of Clinical Investigation, 1993